Text Size:
Color Theme:

Company Information

Revenue, expenses and profitability over five years.

Income Statement

MOREPEN LABORATORIES LTD.

NSE Code
MOREPENLABEQ
BSE Code
500288
ISIN
INE083A01026
Industry
Pharmaceuticals
Financial Data

Income Statement

All amounts are in ₹ crore unless stated otherwise.

Showing Standalone data

Table can be scrolled horizontally on smaller screens.

Five-year standalone Income Statement for the selected company
ParticularsMar 26Mar 25Mar 24Mar 23Mar 22
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue2.002.002.002.002.00
INCOME
Revenue From Operations [Net]1681.201546.941529.431335.481446.05
Other Operating Revenues0.007.598.163.403.22
Total Operating Revenues1681.201554.541537.591338.881449.27
Other Income21.5015.7212.575.7610.24
Total Revenue1702.691570.251550.161344.641459.50
EXPENSES
Cost Of Materials Consumed1043.11999.18883.31781.41797.13
Purchase Of Stock-In Trade15.0220.8161.84105.07191.68
Changes In Inventories Of FG,WIP And Stock-In Trade3.23-44.365.1316.541.74
Employee Benefit Expenses206.28177.22160.28146.19150.00
Finance Costs16.107.103.511.98-7.37
Depreciation And Amortisation Expenses29.3124.4421.9018.0121.19
Other Expenses301.48248.27265.22212.40179.58
Total Expenses1614.521432.671401.181281.601333.96
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax88.17137.59148.9863.04125.54
Exceptional Items1.100.000.000.000.00
Profit/Loss Before Tax89.26137.59148.9863.04125.54
Tax Expenses-Continued Operations
Current Tax23.2131.2838.5716.6024.62
Deferred Tax0.004.73-0.440.202.48
Tax For Earlier Years0.000.00-0.090.00-2.63
Total Tax Expenses23.2136.0138.0416.8024.48
Profit/Loss After Tax And Before ExtraOrdinary Items66.06101.58110.9446.24101.06
Profit/Loss From Continuing Operations66.06101.58110.9446.24101.06
Profit/Loss For The Period66.06101.58110.9446.24101.06
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)1.211.902.170.922.25
Diluted EPS (Rs.)1.211.902.170.921.94
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Dividend Rate (%)10.0010.000.000.000.00

Source: Financial statements as reported by the company.